✦ LIBER ✦

Development of Aptamer oligonucleotides as Anticoagulants and Antithrombotics for Cardiovascular Diseases: Current Status

✍ Scribed by Li, Weibin; Wang, Kaiyu; Zhao, Meng; Yang, Xiangyue; Chen, Min; Lan, Xiaopeng

Book ID: 124147176
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 239 KB
Volume: 134
Category: Article
ISSN: 0049-3848
DOI: 10.1016/j.thromres.2014.05.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drugs for the control of parasitic disea

Drugs for the control of parasitic diseases: current status and development

✍ Bill M. Watkins 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Current issues of gene therapy for cardi

Current issues of gene therapy for cardiovascular disorders and antithrombotic therapy in chronic heart disease

✍ Valentin Fuster 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 31 KB

Drugs for the control of parasitic disea

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

✍ Alan Fenwick; Lorenzo Savioli; Dirk Engels; N. Robert Bergquist; Matthew H. Todd 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Relationship between aging and dosage of

Relationship between aging and dosage of warfarin: The current status of warfarin anticoagulant therapy for Japanese outpatients in a department of cardiovascular medicine

✍ Takeshi Miura; Toru Nishinaka; Tomoyuki Terada; Kazuya Yonezawa 📂 Article 📅 2009 🏛 Elsevier 🌐 Japanese ⚖ 171 KB

Audiometric pattern as a predictor of ca

Audiometric pattern as a predictor of cardiovascular status: Development of a model for assessment of risk

✍ David R. Friedland; Christopher Cederberg; Sergey Tarima 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

## Abstract ## Objectives/Hypothesis: This study hypothesizes that low‐frequency hearing loss is associated with underlying cardiovascular disease. The objective of this study was to use a mathematical model of hearing thresholds to predict cardiovascular status. ## Study Design: Logistic regres

The current status of, and challenges in

The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection

✍ Kenji Maeda; Hirotomo Nakata; Hiromi Ogata; Yasuhiro Koh; Toshikazu Miyakawa; Hi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 156 KB